© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
January 27, 2022
The first doses of Moderna and IAVI’s mRNA HIV vaccine have been administered in the phase 1 IAVI G002 clinical trial.
January 21, 2022
Providers of patients with HIV should have greater sensitivity to symptoms of heart failure, the study authors suggested.
The study authors observed reductions in three types of orphanhood, including paternal-only, maternal-only, and double orphanhood.
January 18, 2022
In utilizing a modeling study, investigators estimated reductions in HIV incidence rates as well as PrEP usage rates and viral suppression across US cities over 10 years.
January 12, 2022
Investigators used an updated “kick and kill” strategy to expose and eliminate dormant infected cells in HIV-positive mice.
There is a high level of engagement in HIV care observed among pregnant women, which displays a commitment to their health and wellbeing during their pregnancy, the study authors wrote.
January 10, 2022
The AIDS Clinical Trials Group (ACTG) is beginning stage 2 trials for Triplex, a novel vaccine for people living with HIV and cytomegalovirus (CMV).
January 09, 2022
By 2030, the US is targeting reducing the number of new HIV infections by 90 percent.
January 06, 2022
Dolutegravir-based antiretroviral therapy proved more effective than standard treatments for HIV-positive children, reducing treatment failure by 40%.
January 02, 2022
Investigators compared pre- and post-intervention data points at 4 clinics in Kenya.